Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001092257 | SCV001248676 | likely pathogenic | not provided | 2019-08-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001873452 | SCV002184099 | pathogenic | Intellectual disability, autosomal dominant 5 | 2021-04-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Thr790Profs*21) in the SYNGAP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SYNGAP1 are known to be pathogenic (PMID: 23161826, 23708187, 26989088). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SYNGAP1-related conditions. For these reasons, this variant has been classified as Pathogenic. |